These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37080175)

  • 21. Daily fosfomycin versus levofloxacin for complicated urinary tract infections.
    Rouphael N; Winokur P; Keefer MC; Traenkner J; Drobeniuc A; Doi Y; Munsiff S; Fowler VG; Evans S; Oler RE; Tuyishimire B; Lee M; Ghazaryan V; Chambers HF;
    mBio; 2023 Oct; 14(5):e0167723. PubMed ID: 37698412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experience of using the antibacterial drug Fosfomycin Esparma for the treatment of acute uncomplicated cystitis in women].
    Aboyan IA; Orlov YN; Voloshina OA; Orlov NV; Pavlov DS
    Urologiia; 2019 Sep; (4):20-25. PubMed ID: 31535800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrent uncomplicated cystitis in women: allowing patients to self-initiate antibiotic therapy.
    Prescrire Int; 2014 Feb; 23(146):47-9. PubMed ID: 24669389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 2017 Update of the German Clinical Guideline on Epidemiology, Diagnostics, Therapy, Prevention, and Management of Uncomplicated Urinary Tract Infections in Adult Patients. Part II: Therapy and Prevention.
    Kranz J; Schmidt S; Lebert C; Schneidewind L; Mandraka F; Kunze M; Helbig S; Vahlensieck W; Naber K; Schmiemann G; Wagenlehner FM
    Urol Int; 2018; 100(3):271-278. PubMed ID: 29539622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and management of urinary tract infections in the outpatient setting: a review.
    Grigoryan L; Trautner BW; Gupta K
    JAMA; 2014 Oct 22-29; 312(16):1677-84. PubMed ID: 25335150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adherence to guideline recommendations for urinary tract infections in adult women: a cross-sectional study.
    Lelie-van der Zande R; Bouvy M; Teichert M
    Prim Health Care Res Dev; 2021 Apr; 22():e11. PubMed ID: 33818360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Rationale for choosing an antibiotic for the treatment of cystitis: recommendations of clinical pharmacologists: A review].
    Yakovlev SV; Suvorova MP
    Ter Arkh; 2022 Oct; 94(8):1006-1013. PubMed ID: 36286982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Nitrofurantoin--clinical relevance in uncomplicated urinary tract infections].
    Stock I
    Med Monatsschr Pharm; 2014 Jul; 37(7):242-8. PubMed ID: 25065160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antibiotic resistance and antibiotic consumption in a region - using the example of community-acquired urinary tract infections].
    Heudorf U; Weindel M; Wagenlehner F
    Aktuelle Urol; 2021 Aug; 52(4):345-355. PubMed ID: 34134150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cefaclor as a first-line treatment for acute uncomplicated cystitis: a retrospective single-center study.
    Koguchi D; Murakami Y; Ikeda M; Dobashi M; Ishii J
    BMC Urol; 2020 Apr; 20(1):38. PubMed ID: 32252747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-dose treatment of acute cystitis with fosfomycin tromethamine.
    Stein GE
    Ann Pharmacother; 1998 Feb; 32(2):215-9. PubMed ID: 9496408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral treatment options for ambulatory patients with urinary tract infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli.
    Auer S; Wojna A; Hell M
    Antimicrob Agents Chemother; 2010 Sep; 54(9):4006-8. PubMed ID: 20585127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The current management strategies for community-acquired urinary tract infection.
    Hooton TM
    Infect Dis Clin North Am; 2003 Jun; 17(2):303-32. PubMed ID: 12848472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Practice guidelines for the treatment of uncomplicated cystitis.
    Warren JW
    Curr Urol Rep; 2001 Aug; 2(4):326-9. PubMed ID: 12084260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SUsceptibility and Resistance to Fosfomycin and other antimicrobial agents among pathogens causing lower urinary tract infections: findings of the SURF study.
    Tutone M; Bjerklund Johansen TE; Cai T; Mushtaq S; Livermore DM
    Int J Antimicrob Agents; 2022 May; 59(5):106574. PubMed ID: 35307561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral treatment options for patients with urinary tract infections caused by extended spectrum βeta-lactamase (ESBL) producing Enterobacteriaceae.
    Raja NS
    J Infect Public Health; 2019; 12(6):843-846. PubMed ID: 31176606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do different susceptibility breakpoints affect the selection of antimicrobials for treatment of uncomplicated cystitis?
    Schito GC; Gualco L; Naber KG; Botto H; Palou J; Mazzei T; Marchese A
    J Chemother; 2010 Oct; 22(5):345-54. PubMed ID: 21123159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents.
    Bader MS; Loeb M; Leto D; Brooks AA
    Postgrad Med; 2020 Apr; 132(3):234-250. PubMed ID: 31608743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Uncomplicated urinary tract infection and treatment].
    Wagenlehner FM; Vahlensieck W; Watermann D; Weidner W; Naber KG
    Aktuelle Urol; 2011 Jan; 42(1):33-7. PubMed ID: 21267803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis and treatment of acute uncomplicated cystitis.
    Colgan R; Williams M
    Am Fam Physician; 2011 Oct; 84(7):771-6. PubMed ID: 22010614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.